• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
PALB2 Interest Group

PALB2 Interest Group

  • About
    • PALB2 gene
    • PALB2 mutation and cancer risks
    • A Study of Cancer Risks in PALB2 Mutation Carriers
    • Clinician Info
    • FAQs
  • Team
    • PALB2 Interest Group
    • Our Team
    • Our Collaborators
  • Resources
  • Publications
  • Events
  • Contact Us

News

Goodbye Breasts! An award-winning feature documentary by Joanna Callaghan.

24th March 2026

Following our sold-out, award-winning premiere at Brighton Cinecity Film Festival, we are thrilled to announce a screening tour this April and May! Join Joanna and local experts for post-screening Q&As …

Read moreGoodbye Breasts! An award-winning feature documentary by Joanna Callaghan.

PALB2 at 20 – should we now call it “BRCA3”

13th March 2026

In this webinar for the GENTURIS European Reference Network, Marc Tischkowitz gives an update on PALB2 and puts forward the argument for calling it BRCA3. Please click here to view …

Read morePALB2 at 20 – should we now call it “BRCA3”

New study shows that PARP inhibitors are effective in PALB2-related breast cancer

7th March 2026

Read more here

Read moreNew study shows that PARP inhibitors are effective in PALB2-related breast cancer

5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time

17th November 2025

Our 5th UK Annual PALB2 formation Session is designed for people of all genders who carry a PALB2 gene mutation and would like to learn more about the gene and its implications. The session …

Read more5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time

UK PALB2 Carriers Information Session (4th annual event) 16th October 2024

23rd March 2025

UK PALB2 Carriers Information Session (4th annual event) 16th October 2024 can be viewed here:

Read moreUK PALB2 Carriers Information Session (4th annual event) 16th October 2024

ASCO Post – Commentary on the PALB2 ACMG Management Guidelines

12th October 2021

ASCO Post have featured the ACMG PALB2 Management Guidelines with comments from on of the authors, Dr Doug Stewart. Dr. Stewart is Senior Investigator, Clinical Genetics Branch, Division of Cancer …

Read moreASCO Post – Commentary on the PALB2 ACMG Management Guidelines
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next

Our Researchers are funded by many organisations including:

European Research Council
Cancer Research UK

Copyright © 2026 · PALB2 Interest Group · All Rights Reserved